{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T09:18:25Z","timestamp":1780391905138,"version":"3.54.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T00:00:00Z","timestamp":1775865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"vor","delay-in-days":52,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"SRM Institute of Science & Technology"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-47205-2","type":"journal-article","created":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T03:47:03Z","timestamp":1775879223000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A comparative in silico and in vitro analysis of antiviral agents targeting estrogen and progesterone receptors in breast cancer"],"prefix":"10.1038","volume":"16","author":[{"given":"Uma Maheshwari","family":"Mugundan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venkatesan","family":"Saravanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajanandh Muhasaparur","family":"Ganesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,11]]},"reference":[{"key":"47205_CR1","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1038\/s41591-025-03502-3","volume":"31","author":"J Kim","year":"2025","unstructured":"Kim, J. et al. Global patterns and trends in breast cancer incidence and mortality across 185 countries. Nat. Med. 31, 1154\u20131162 (2025).","journal-title":"Nat. Med."},{"key":"47205_CR2","doi-asserted-by":"publisher","first-page":"5350","DOI":"10.3390\/cancers13215350","volume":"13","author":"H Shaath","year":"2021","unstructured":"Shaath, H., Elango, R. & Alajez, N. M. Molecular classification of breast cancer utilizing long non-coding RNA (lncRNA) transcriptomes identifies novel diagnostic lncRNA panel for triple-negative breast cancer. Cancers (Basel). 13, 5350 (2021).","journal-title":"Cancers (Basel)"},{"key":"47205_CR3","first-page":"688","volume":"26","author":"E Lim","year":"2012","unstructured":"Lim, E., Metzger-Filho, O. & Winer, E. P. The natural history of hormone receptor-positive breast cancer. Oncology 26, 688\u2013696 (2012).","journal-title":"Oncology"},{"key":"47205_CR4","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s10549-018-5023-4","volume":"173","author":"M Szostakowska","year":"2019","unstructured":"Szostakowska, M., Tr\u0119bi\u0144ska-Stryjewska, A., Grzybowska, E. A. & Fabisiewicz, A. Resistance to endocrine therapy in breast cancer: molecular mechanisms and future goals. Breast Cancer Res. Treat. 173, 489\u2013497 (2019).","journal-title":"Breast Cancer Res. Treat."},{"key":"47205_CR5","doi-asserted-by":"publisher","first-page":"100939","DOI":"10.1016\/j.mam.2020.100939","volume":"78","author":"I Mayayo-Peralta","year":"2021","unstructured":"Mayayo-Peralta, I., Prekovic, S. & Zwart, W. Estrogen receptor on the move: Cistromic plasticity and its implications in breast cancer. Mol. Aspects Med. 78, 100939 (2021).","journal-title":"Mol. Aspects Med."},{"key":"47205_CR6","doi-asserted-by":"publisher","first-page":"305","DOI":"10.2147\/DDDT.S336643","volume":"16","author":"Z Li","year":"2022","unstructured":"Li, Z., Wei, H., Li, S., Wu, P. & Mao, X. The Role of progesterone receptors in breast cancer. Drug Des. Devel Ther. 16, 305\u2013314 (2022).","journal-title":"Drug Des. Devel Ther."},{"key":"47205_CR7","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/nrclinonc.2015.117","volume":"12","author":"R Jeselsohn","year":"2015","unstructured":"Jeselsohn, R., Buchwalter, G., De Angelis, C., Brown, M. & Schiff, R. ESR1 mutations\u2014a mechanism for acquired endocrine resistance in breast cancer. Nat. Rev. Clin. Oncol. 12, 573\u2013583 (2015).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"47205_CR8","doi-asserted-by":"publisher","first-page":"361","DOI":"10.4103\/ijp.ijp_332_24","volume":"56","author":"MU Maheshwari","year":"2024","unstructured":"Maheshwari, M. U. & Rajanandh, M. G. From antiviral to anticancer: Exploring efavirenz\u2019s potential against breast cancer. Indian J. Pharmacol. 56, 361\u2013362 (2024).","journal-title":"Indian J. Pharmacol."},{"key":"47205_CR9","first-page":"e67776","volume":"16","author":"VD Elango","year":"2024","unstructured":"Elango, V. D., Mugundan, U. M. & Mg, R. Efavirenz: new hope in cancer therapy. Cureus 16, e67776 (2024).","journal-title":"Cureus"},{"key":"47205_CR10","doi-asserted-by":"publisher","first-page":"100812","DOI":"10.1016\/j.chphi.2024.100812","volume":"10","author":"UM Mugundan","year":"2025","unstructured":"Mugundan, U. M. & Sekar, P. Muhasaparur Ganesan, R. Repurposing antiviral drugs targeting the PARP-1 and HER2 pathways with multifaceted impacts through integrated network analysis and molecular mechanics. Chem. Phys. Impact. 10, 100812 (2025).","journal-title":"Chem. Phys. Impact"},{"key":"47205_CR11","unstructured":"National Cancer Institute. Hormone Therapy for Breast Cancer. National Cancer Institute (2022)."},{"key":"47205_CR12","doi-asserted-by":"publisher","first-page":"16759","DOI":"10.1021\/acsomega.4c00906","volume":"9","author":"VH Masand","year":"2024","unstructured":"Masand, V. H. et al. Estrogen receptor alpha binders for hormone-dependent forms of breast cancer: e-QSAR and molecular docking supported by X-ray resolved structures. ACS Omega. 9, 16759\u201316774 (2024).","journal-title":"ACS Omega"},{"key":"47205_CR13","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/30775","volume":"393","author":"SP Williams","year":"1998","unstructured":"Williams, S. P. & Sigler, P. B. Atomic structure of progesterone complexed with its receptor. Nature 393, 392\u2013396 (1998).","journal-title":"Nature"},{"key":"47205_CR14","doi-asserted-by":"crossref","unstructured":"Priyankha, S. et al. The Virtual Screening of Compounds from the ZINC Database against PARP-1 in Triple\u2010Negative Breast Cancer. ChemistrySelect 9, (2024).","DOI":"10.1002\/slct.202304729"},{"key":"47205_CR15","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.procbio.2024.04.012","volume":"142","author":"SPRR Nayak","year":"2024","unstructured":"Nayak, S. P. R. R. et al. Furan-based chalcone protects \u03b2-cell damage and improves glucose uptake in alloxan-induced zebrafish diabetic model via influencing Peroxisome Proliferator-Activated Receptor agonists (PPAR-\u03b3) signaling. Process Biochem. 142, 149\u2013161 (2024).","journal-title":"Process Biochem."},{"key":"47205_CR16","doi-asserted-by":"publisher","first-page":"788","DOI":"10.3390\/biomedicines12040788","volume":"12","author":"P Deivasigamani","year":"2024","unstructured":"Deivasigamani, P. et al. Dual anti-inflammatory and anticancer activity of novel 1,5-diaryl pyrazole derivatives: molecular modeling, synthesis, in vitro activity, and dynamics study. Biomedicines 12, 788 (2024).","journal-title":"Biomedicines"},{"key":"47205_CR17","doi-asserted-by":"publisher","first-page":"3346","DOI":"10.1039\/D3RA08618F","volume":"14","author":"V Saravanan","year":"2024","unstructured":"Saravanan, V., Chagaleti, B. K., Packiapalavesam, S. D. & Kathiravan, M. Ligand based pharmacophore modelling and integrated computational approaches in the quest for small molecule inhibitors against hCA IX. RSC Adv. 14, 3346\u20133358 (2024).","journal-title":"RSC Adv."},{"key":"47205_CR18","doi-asserted-by":"publisher","first-page":"151471","DOI":"10.1016\/j.bbrc.2025.151471","volume":"753","author":"V Saravanan","year":"2025","unstructured":"Saravanan, V. et al. Molecular dynamics simulation reveals structural insights into isozyme selectivity of carbonic anhydrase XII inhibitors in hypoxic tumor microenvironment. Biochem. Biophys. Res. Commun. 753, 151471 (2025).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"47205_CR19","doi-asserted-by":"publisher","first-page":"100769","DOI":"10.1016\/j.chphi.2024.100769","volume":"9","author":"NM Mhetre","year":"2024","unstructured":"Mhetre, N. M. et al. Rational design of some 1,3,4 trisubstituted pyrazole-thiazole derivatives to serve as MtInhA inhibitors using QSAR, ADMET, molecular docking, MM-GBSA, and molecular dynamics simulations approach. Chem. Phys. Impact. 9, 100769 (2024).","journal-title":"Chem. Phys. Impact"},{"key":"47205_CR20","doi-asserted-by":"publisher","first-page":"108073","DOI":"10.1016\/j.compbiolchem.2024.108073","volume":"110","author":"SD Packiapalavesam","year":"2024","unstructured":"Packiapalavesam, S. D. et al. Identification of novel CA IX inhibitor: Pharmacophore modeling, docking, DFT, and dynamic simulation. Comput. Biol. Chem. 110, 108073 (2024).","journal-title":"Comput. Biol. Chem."},{"key":"47205_CR21","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1109\/TCBBIO.2024.3521790","volume":"22","author":"V Saravanan","year":"2025","unstructured":"Saravanan, V., Chagaleti, B. K., Packiapalavesam, S. D. & Kathiravan, M. Ligand-based pharmacophore modeling and quantum computational approaches for the development of hCA XII inhibitor. IEEE Trans. Comput. Biology Bioinf. 22, 503\u2013513 (2025).","journal-title":"IEEE Trans. Comput. Biology Bioinf."},{"key":"47205_CR22","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1021\/acs.jcim.2c00057","volume":"62","author":"V Dalal","year":"2022","unstructured":"Dalal, V., Golemi-Kotra, D. & Kumar, P. Quantum mechanics\/molecular mechanics studies on the catalytic mechanism of a novel esterase (FmtA) of Staphylococcus aureus. J. Chem. Inf. Model. 62, 2409\u20132420 (2022).","journal-title":"J. Chem. Inf. Model."},{"key":"47205_CR23","doi-asserted-by":"publisher","first-page":"132476","DOI":"10.1016\/j.molstruc.2022.132476","volume":"1255","author":"R Kumari","year":"2022","unstructured":"Kumari, R., Rathi, R., Pathak, S. R. & Dalal, V. Structural-based virtual screening and identification of novel potent antimicrobial compounds against YsxC of Staphylococcus aureus. J. Mol. Struct. 1255, 132476 (2022).","journal-title":"J. Mol. Struct."},{"key":"47205_CR24","doi-asserted-by":"publisher","first-page":"8725","DOI":"10.1080\/07391102.2021.1916597","volume":"40","author":"DN Gupta","year":"2022","unstructured":"Gupta, D. N. et al. In-silico screening and identification of potential inhibitors against 2Cys peroxiredoxin of Candidatus Liberibacter asiaticus. J. Biomol. Struct. Dyn. 40, 8725\u20138739 (2022).","journal-title":"J. Biomol. Struct. Dyn."},{"key":"47205_CR25","doi-asserted-by":"publisher","first-page":"3293","DOI":"10.3390\/molecules24183293","volume":"24","author":"JA Bauer","year":"2019","unstructured":"Bauer, J. A. & Pavlovi\u0107, J. Bauerov\u00e1-Hlinkov\u00e1, V. Normal mode analysis as a routine part of a structural investigation. Molecules 24, 3293 (2019).","journal-title":"Molecules"},{"key":"47205_CR26","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkae909","volume":"53","author":"M Kanehisa","year":"2025","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Matsuura, Y. & Ishiguro-Watanabe, M. KEGG: biological systems database as a model of the real world. Nucleic Acids Res. 53, D672\u2013D677 (2025).","journal-title":"Nucleic Acids Res."},{"key":"47205_CR27","doi-asserted-by":"publisher","first-page":"139116","DOI":"10.1016\/j.molstruc.2024.139116","volume":"1317","author":"Y Laamari","year":"2024","unstructured":"Laamari, Y. et al. Multitargeted molecular docking and dynamics simulation of thymol-based chalcones against cancer protein markers: Synthesis, characterization, and computational study. J. Mol. Struct. 1317, 139116 (2024).","journal-title":"J. Mol. Struct."},{"key":"47205_CR28","doi-asserted-by":"publisher","first-page":"153008","DOI":"10.1016\/j.bbrc.2025.153008","volume":"793","author":"M Arjun Gokulan","year":"2025","unstructured":"Arjun Gokulan, M. & Narayanan, J. Exploring benzhydroxamic acid as a multi-target lead: Integrated strategies of network pharmacology, molecular docking, dynamic simulations, and MM\/GBSA analysis for neuropathic pain therapy. Biochem. Biophys. Res. Commun. 793, 153008 (2025).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"47205_CR29","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s40011-019-01122-9","volume":"90","author":"C Jerard","year":"2020","unstructured":"Jerard, C., Michael, B. P., Chenicheri, S., Vijayakumar, N. & Ramachandran, R. Rosmarinic acid-rich fraction from mentha arvensis synchronizes Bcl\/Bax expression and induces Go\/G1 arrest in hepatocarcinoma cells. Proc. Natl. Acad. Sci. India Sect. B: Biol. Sci. 90, 515\u2013522 (2020).","journal-title":"Proc. Natl. Acad. Sci. India Sect. B: Biol. Sci."},{"key":"47205_CR30","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","volume":"65","author":"T Mosmann","year":"1983","unstructured":"Mosmann, T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Methods. 65, 55\u201363 (1983).","journal-title":"J. Immunol. Methods"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47205-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47205-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47205-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T08:46:59Z","timestamp":1780390019000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47205-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,11]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["47205"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-47205-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,11]]},"assertion":[{"value":"7 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16882"}}